GSK

GSK plc

41.82 USD
-0.52 (-1.23%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

GSK plc stock is up 6.98% since 30 days ago. The next earnings date is Apr 24, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.94% of the previous 50 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
22 Feb 15:28 16 Aug, 2024 42.00 CALL 120 668
22 Feb 16:12 16 Aug, 2024 42.00 PUT 156 425
22 Feb 18:38 17 Jan, 2025 42.00 CALL 192 2284
23 Feb 16:15 15 Mar, 2024 40.00 CALL 114 27
23 Feb 16:51 17 May, 2024 41.00 CALL 100 2595
23 Feb 18:45 17 Jan, 2025 37.00 CALL 46 3124
27 Feb 16:02 17 Jan, 2025 25.00 CALL 17 167
27 Feb 17:18 16 Aug, 2024 47.00 PUT 80 386
27 Feb 19:32 17 May, 2024 41.00 CALL 100 2608
29 Feb 16:21 16 Aug, 2024 38.00 CALL 137 122

About GSK plc

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital.